Literature DB >> 358764

Verapamil and pulmonary hypertension.

K Landmark, A M Refsum, S Simonsen, O Storstein.   

Abstract

We report on the effect of verapamil in 12 patients suffering from pulmonary hypertension. The drug caused a slight, but statistically significant decrease in mean pulmonary artery pressure and in the work performance by the right ventricle. The mean pressure of the right atrium, the end-diastolic pressure of the right ventricle, the pulmonary arteriolar resistance, the cardiac index and the stroke volume were not significantly changed, however, and there was a wide spread of the values observed. In some patients the drug exerted a marked negative inotropic effect, with a concomitant increase in the pulmonary arteriolar resistance.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 358764     DOI: 10.1111/j.0954-6820.1978.tb08443.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  11 in total

1.  The treatment of primary pulmonary hypertension.

Authors:  N G Uren; C M Oakley
Journal:  Br Heart J       Date:  1991-08

Review 2.  Calcium-channel blockers and anaesthesia.

Authors:  P G Durand; J J Lehot; P Foëx
Journal:  Can J Anaesth       Date:  1991-01       Impact factor: 5.063

3.  Severe pulmonary hypertension in a patient with rheumatoid arthritis--response to nifedipine.

Authors:  S G Lehrman; R C Hollander
Journal:  West J Med       Date:  1986-08

4.  Calcium blockers for cardiac disease: therapeutic implications.

Authors:  A Dodek; J Ruedy
Journal:  Can Med Assoc J       Date:  1983-04-15       Impact factor: 8.262

5.  Primary pulmonary hypertension: modern approaches to an old problem.

Authors:  S Fein; W Frishman
Journal:  Lung       Date:  1980       Impact factor: 2.584

Review 6.  Drug treatment of primary pulmonary hypertension.

Authors:  A A McLeod; D E Jewitt
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

7.  Effects of verapamil on pulmonary haemodynamics during hypoxaemia, at rest, and during exercise in patients with chronic obstructive pulmonary disease.

Authors:  S E Brown; G S Linden; R R King; G P Blair; D W Stansbury; R W Light
Journal:  Thorax       Date:  1983-11       Impact factor: 9.139

Review 8.  Calcium antagonists. Pharmacodynamic effects and mechanism of action.

Authors:  T T Zsotér; J G Church
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

9.  Detrimental effects of verapamil in patients with primary pulmonary hypertension.

Authors:  M Packer; N Medina; M Yushak; I Wiener
Journal:  Br Heart J       Date:  1984-07

10.  Haemodynamic response to intravenous hydralazine in patients with pulmonary hypertension.

Authors:  M D McGoon; J B Seward; R E Vlietstra; M H Choo; T P Moyer; G S Reeder
Journal:  Br Heart J       Date:  1983-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.